Sildenafil Citrate Tablet, Film Coated
Product Images NDC 27241-067

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 27241-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Line graph showing mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers after dosing with Sildenafil 100 mg or placebo. The x-axis represents time post dose in hours, and the y-axis represents change in systolic blood pressure in mmHg. The graph compares the effect of Sildenafil versus placebo over the time course.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes over an 8-hour period. Two data series compare Doxazosin plus Placebo and Doxazosin plus Sildenafil 50 mg, with time postdose on the x-axis and change in systolic blood pressure (mmHg) on the y-axis.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes over time after dosing. The x-axis represents time in hours (0 to 8), and the y-axis represents change in mmHg (-50 to 40). Two lines compare Doxazosin + Sildenafil 100 mg and Doxazosin + Placebo groups, illustrating blood pressure changes over 8 hours.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph titled 'Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' depicting plasma concentrations (ng/ml) over time post dose (hours) for a commercial Sildenafil tablet. The curve shows a rapid increase in plasma levels peaking around 1 hour, followed by a gradual decline over 24 hours.*

FDA Label Image

Sildenafil 100mg

Label for Sildenafil Tablets, USP 100 mg film-coated tablets by Ajanta Pharma USA Inc. The label indicates 100 tablets per package, with child-resistant packaging. It includes storage instructions, dispensing advice to pharmacists, and the NDC 27241-069-10. The label design features green and black text on a white background with a barcode on the right.*

FDA Label Image

Sildenafil 25mg

Label for Sildenafil Tablets USP 25 mg film-coated oral tablets by Ajanta Pharma USA Inc. The package contains 30 tablets. The label includes storage instructions, child-resistant packaging notice, pharmacist dispensing instructions, and the NDC code 27241-067-03. The label also notes the product is marketed by Ajanta Pharma USA Inc., Bridgewater, NJ, and made in India.*

FDA Label Image

Sildenafil 50mg

Sildenafil Tablets, USP 50 mg film-coated tablets label from Ajanta Pharma USA Inc. The label states the package contains 100 tablets, with each tablet containing sildenafil citrate equivalent to 50 mg sildenafil. It includes storage instructions, child-resistant packaging notice, prescribing information note, and a barcode.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

A vertical bar chart showing percentage of patients reporting improvement in erectile function across four treatment groups: Placebo, Sildenafil Tablets 25 mg, Sildenafil Tablets 50 mg, and Sildenafil Tablets 100 mg. The percentages increase from placebo (24%) to Sildenafil 25 mg (63%), 50 mg (74%), and 100 mg (82%).*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure diagram of Sildenafil, the active ingredient in Sildenafil Citrate tablets. The diagram shows the molecular arrangement of atoms characteristic of the Sildenafil molecule.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph comparing the change in blood pressure (DBP in mmHg) over time postdose (hours) between two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The x-axis represents time in hours, and the y-axis shows the change in DBP values, with two plotted lines depicting the trends for each group.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart displaying percentages of patients at endpoint based on baseline scores ranging from 0 to 5. Different shaded bars represent various groups or conditions, with the y-axis showing percentage values and the x-axis indicating baseline score categories.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart showing the percentage of patients at endpoint categorized by baseline score. The x-axis represents the baseline score ranging from 0 to 5, while the y-axis shows the percentage of patients, ranging from 0 to 80%. Multiple bars for each baseline score indicate different data groups or treatments, as labeled on the right side of the figure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.